Document is current

Any future updates will be listed below

Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial

Crossref DOI link: https://doi.org/10.1038/s41392-025-02544-w

Published Online: 2026-01-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark